1-chloroethyl acetate - CAS 5912-58-3
Catalog: |
BB055648 |
Product Name: |
1-chloroethyl acetate |
CAS: |
5912-58-3 |
Synonyms: |
1-Chloroethyl acetate; 1-Chloroethanol acetate; Ethanol, 1-chloro-, acetate; a-Chloroethyl acetate; acetic acid 1-chloroethyl ester; acetic acid 1-chloro-ethyl ester; alpha-chloroethyl acetate; 1-Chloroethylacetate |
IUPAC Name: | 1-chloroethyl acetate |
Description: | 1-chloroethyl acetate (cas# 5912-58-3) is a useful research chemical. |
Molecular Weight: | 122.55 |
Molecular Formula: | C4H7O2Cl |
Canonical SMILES: | CC(OC(=O)C)Cl |
InChI: | InChI=1S/C4H7ClO2/c1-3(5)7-4(2)6/h3H,1-2H3 |
InChI Key: | CGKKDGMMKSOGLM-UHFFFAOYSA-N |
Solubility: | Chloroform (Sparingly), Methanol (Slightly) |
Appearance: | Brown Oil |
Storage: | Hygroscopic, Refrigerator, under inert atmosphere |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112194581-A | Preparation method of flurbiprofen axetil | 20200915 |
WO-2022052936-A1 | Aryl propionic acid derivative, pharmaceutical composition, and method for preparation thereof and application thereof | 20200909 |
CN-114075109-A | Preparation method of flurbiprofen axetil and prepared crystal form | 20200821 |
CN-111999405-A | Separation and detection method of flurbiprofen axetil and defluorinated flurbiprofen axetil | 20200814 |
CN-113636933-A | Method for purifying flurbiprofen axetil | 20200511 |
TW-202130619-A | Prodrug of nitroxoline and use thereof | 20200214 |
CN-110759906-A | Prodrug of Fevipiprant and preparation method and application thereof | 20191011 |
US-10875845-B2 | Compounds and methods for the treatment of ocular disorders | 20190418 |
US-2020331896-A1 | Compounds and methods for the treatment of ocular disorders | 20190418 |
WO-2020212755-A1 | Compounds and methods for the treatment of ocular disorders | 20190418 |
Complexity: | 72.1 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 122.0134572 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 122.0134572 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 26.3Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS